Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 72 items for :

  • non-alcoholic fatty liver disease x
Clear All
Yansu Wang Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai, China

Search for other papers by Yansu Wang in
Google Scholar
PubMed Close
,
Yun Shen Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai, China

Search for other papers by Yun Shen in
Google Scholar
PubMed Close
,
Tingting Hu Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai, China

Search for other papers by Tingting Hu in
Google Scholar
PubMed Close
,
Yufei Wang Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai, China

Search for other papers by Yufei Wang in
Google Scholar
PubMed Close
,
Xiaojing Ma Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai, China

Search for other papers by Xiaojing Ma in
Google Scholar
PubMed Close
,
Haoyong Yu Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai, China

Search for other papers by Haoyong Yu in
Google Scholar
PubMed Close
, and
Yuqian Bao Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai, China

Search for other papers by Yuqian Bao in
Google Scholar
PubMed Close

Introduction Non-alcoholic fatty liver disease (NAFLD) is a metabolic stress-induced liver injury that is pathologically manifested by excessive triglyceride deposition in hepatocytes. It is the most prevalent chronic liver disease worldwide

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0545
Volume/Issue:
Volume 12: Issue 7
Open access
Iben Rix Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Zealand Pharma A/S, Søborg, Denmark

Search for other papers by Iben Rix in
Google Scholar
PubMed Close
,
Marie L Johansen Department of Medicine, Herlev Hospital, University of Copenhagen, Herlev, Denmark

Search for other papers by Marie L Johansen in
Google Scholar
PubMed Close
,
Asger Lund Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Asger Lund in
Google Scholar
PubMed Close
,
Malte P Suppli Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Malte P Suppli in
Google Scholar
PubMed Close
,
Elizaveta Chabanova Department of Radiology, Herlev Hospital, University of Copenhagen, Herlev, Denmark

Search for other papers by Elizaveta Chabanova in
Google Scholar
PubMed Close
,
Gerrit van Hall Clinical Metabolomics Core Facility, Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Gerrit van Hall in
Google Scholar
PubMed Close
,
Jens J Holst Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jens J Holst in
Google Scholar
PubMed Close
,
Nicolai J Wewer Albrechtsen Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Nicolai J Wewer Albrechtsen in
Google Scholar
PubMed Close
,
Caroline Kistorp Department of Endocrinology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Caroline Kistorp in
Google Scholar
PubMed Close
, and
Filip K Knop Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Herlev, Denmark

Search for other papers by Filip K Knop in
Google Scholar
PubMed Close

restoring amino acid turnover. The price for this is, however, that glucose production increases, as glucagon action on glucose production seems to be preserved in non-alcoholic fatty liver disease (NAFLD) ( 10 , 12 ). The mechanisms underlying this hepatic

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0161
Volume/Issue:
Volume 13: Issue 1
Open access
Jun-Xin Yan The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China

Search for other papers by Jun-Xin Yan in
Google Scholar
PubMed Close
,
Bin-Jing Pan The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China

Search for other papers by Bin-Jing Pan in
Google Scholar
PubMed Close
,
Ping-Ping Zhao The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China

Search for other papers by Ping-Ping Zhao in
Google Scholar
PubMed Close
,
Li-Ting Wang The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China

Search for other papers by Li-Ting Wang in
Google Scholar
PubMed Close
,
Jing-Fang Liu The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China

Search for other papers by Jing-Fang Liu in
Google Scholar
PubMed Close
, and
Song-Bo Fu The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China

Search for other papers by Song-Bo Fu in
Google Scholar
PubMed Close

Introduction Non-alcoholic fatty liver disease (NAFLD), which is the excessive deposition of fat (>5% of the liver weight) in liver cells without causes such as heavy drinking, hypothyroidism, or drugs, is considered a liver manifestation of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0367
Volume/Issue:
Volume 10: Issue 12
Open access
Robert Maidstone Oxford Centre for Diabetes, Endocrinology and Metabolism, and Oxford Kavli Centre for Nanoscience Discovery, University of Oxford, Oxford, UK
Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK

Search for other papers by Robert Maidstone in
Google Scholar
PubMed Close
,
Martin K Rutter Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester, UK

Search for other papers by Martin K Rutter in
Google Scholar
PubMed Close
,
Thomas Marjot Oxford Centre for Diabetes, Endocrinology and Metabolism, and Oxford Kavli Centre for Nanoscience Discovery, University of Oxford, Oxford, UK
Oxford Liver Unit, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, UK

Search for other papers by Thomas Marjot in
Google Scholar
PubMed Close
,
David W Ray Oxford Centre for Diabetes, Endocrinology and Metabolism, and Oxford Kavli Centre for Nanoscience Discovery, University of Oxford, Oxford, UK
NIHR Oxford Health Biomedical Research Centre, and NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK

Search for other papers by David W Ray in
Google Scholar
PubMed Close
, and
Matthew Baxter Oxford Centre for Diabetes, Endocrinology and Metabolism, and Oxford Kavli Centre for Nanoscience Discovery, University of Oxford, Oxford, UK
NIHR Oxford Health Biomedical Research Centre, and NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK

Search for other papers by Matthew Baxter in
Google Scholar
PubMed Close

for the Study of the Liver (EASL) , European Association for the Study of Diabetes (EASD) & European Association for the Study of Obesity (EASO) . EASL-EASD-EASO Clinical practice guidelines for the management of non-alcoholic fatty liver disease

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0472
Volume/Issue:
Volume 13: Issue 2
Open access
Zhiyan Yu Department of Endocrinology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

Search for other papers by Zhiyan Yu in
Google Scholar
PubMed Close
,
Yueyue Wu Department of Endocrinology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

Search for other papers by Yueyue Wu in
Google Scholar
PubMed Close
,
Rui Zhang Department of Endocrinology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

Search for other papers by Rui Zhang in
Google Scholar
PubMed Close
,
Yue Li Department of Endocrinology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

Search for other papers by Yue Li in
Google Scholar
PubMed Close
,
Shufei Zang Department of Endocrinology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

Search for other papers by Shufei Zang in
Google Scholar
PubMed Close
, and
Jun Liu Department of Endocrinology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

Search for other papers by Jun Liu in
Google Scholar
PubMed Close

factor-1 and hypoalbuminemia. Non-alcoholic fatty liver disease (NAFLD) affecting multiple extrahepatic organs is considered a multi-system disease ( 2 ). Recent studies have shown that NAFLD is a high risk factor for osteoporosis ( 3 ). Several studies

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0174
Volume/Issue:
Volume 11: Issue 11
Open access
David Koeckerling Medical Sciences Division, University of Oxford, Oxford, UK

Search for other papers by David Koeckerling in
Google Scholar
PubMed Close
,
Jeremy W Tomlinson Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, UK

Search for other papers by Jeremy W Tomlinson in
Google Scholar
PubMed Close
, and
Jeremy F Cobbold Oxford Liver Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK

Search for other papers by Jeremy F Cobbold in
Google Scholar
PubMed Close

Why fight liver fat? What is NAFLD? Non-alcoholic fatty liver disease (NAFLD) is recognised as the most common aetiology of chronic liver disease, with an estimated global prevalence of 25.2%, and as a major cause of cirrhosis and

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0174
Volume/Issue:
Volume 9: Issue 7
Open access
Stephen J Winters Division of Endocrinology, Metabolism and Diabetes, University of Louisville, Louisville, Kentucky, USA

Search for other papers by Stephen J Winters in
Google Scholar
PubMed Close
,
Charles R Scoggins Division of Surgical Oncology, University of Louisville, Louisville, Kentucky, USA

Search for other papers by Charles R Scoggins in
Google Scholar
PubMed Close
,
Duke Appiah Department of Public Health, Texas Tech University Health Sciences Center, Lubbock, Texas, USA

Search for other papers by Duke Appiah in
Google Scholar
PubMed Close
, and
Dushan T Ghooray Division of Endocrinology, Metabolism and Diabetes, University of Louisville, Louisville, Kentucky, USA

Search for other papers by Dushan T Ghooray in
Google Scholar
PubMed Close

J Elisaf MS Germanidis G Giouleme O et al . The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0401
Volume/Issue:
Volume 9: Issue 10
Open access
Till Ittermann Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Till Ittermann in
Google Scholar
PubMed Close
,
Rehman Mehmood Khattak Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
Department of Zoology, Islamia College Peshawar (CU), Peshawar, Pakistan

Search for other papers by Rehman Mehmood Khattak in
Google Scholar
PubMed Close
,
Marcello R P Markus Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Marcello R P Markus in
Google Scholar
PubMed Close
,
Jens-Peter Kühn Institute of Radiology, University Hospital, Carl-Gustav-Carus University, Dresden, Germany

Search for other papers by Jens-Peter Kühn in
Google Scholar
PubMed Close
,
Marie-Luise Kromrey Department of Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Marie-Luise Kromrey in
Google Scholar
PubMed Close
,
Giovanni Targher Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy

Search for other papers by Giovanni Targher in
Google Scholar
PubMed Close
,
Antje Steveling Department of Internal Medicine A, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Antje Steveling in
Google Scholar
PubMed Close
,
Matthias Nauck Institute for Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany
DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine, Greifswald, Germany

Search for other papers by Matthias Nauck in
Google Scholar
PubMed Close
, and
Henry Völzke Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Henry Völzke in
Google Scholar
PubMed Close

Introduction Non-alcoholic fatty liver disease (NAFLD) is a common finding in individuals with obesity or type 2 diabetes mellitus and its prevalence is steeply increasing worldwide ( 1 ). Recent meta-analyses of observational studies revealed

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-21-0566
Volume/Issue:
Volume 11: Issue 2
Open access
Helle Keinicke Insulin and Device Trial Operations, Novo Nordisk A/S, Søborg, Denmark

Search for other papers by Helle Keinicke in
Google Scholar
PubMed Close
,
Gao Sun Pharmacology and Histopathology, Novo Nordisk A/S, China

Search for other papers by Gao Sun in
Google Scholar
PubMed Close
,
Caroline M Junker Mentzel Department of Experimental Animal Models, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark

Search for other papers by Caroline M Junker Mentzel in
Google Scholar
PubMed Close
,
Merete Fredholm Department of Veterinary Clinical and Animal Science, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark

Search for other papers by Merete Fredholm in
Google Scholar
PubMed Close
,
Linu Mary John Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark

Search for other papers by Linu Mary John in
Google Scholar
PubMed Close
,
Birgitte Andersen Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark

Search for other papers by Birgitte Andersen in
Google Scholar
PubMed Close
,
Kirsten Raun Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark

Search for other papers by Kirsten Raun in
Google Scholar
PubMed Close
, and
Marina Kjaergaard Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark

Search for other papers by Marina Kjaergaard in
Google Scholar
PubMed Close

Introduction Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in the Western world ( 1 , 2 ) with a global prevalence of 25% ( 3 ). It is defined as steatosis (fat accumulation) in at least 5% of hepatocytes ( 3

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0152
Volume/Issue:
Volume 9: Issue 8
Open access
Xu Chen Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China
Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China

Search for other papers by Xu Chen in
Google Scholar
PubMed Close
,
Yi Tang Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China

Search for other papers by Yi Tang in
Google Scholar
PubMed Close
,
Shen Chen Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China

Search for other papers by Shen Chen in
Google Scholar
PubMed Close
,
Wenhua Ling Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China

Search for other papers by Wenhua Ling in
Google Scholar
PubMed Close
, and
Qing Wang Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China

Search for other papers by Qing Wang in
Google Scholar
PubMed Close

Introduction Non-alcoholic fatty liver disease (NAFLD), which is considered to be the hepatic manifestation of the metabolic syndrome is defined as the abnormal hepatic triglyceride (TG) accumulation without excessive alcohol use. NAFLD

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0353
Volume/Issue:
Volume 10: Issue 10
Open access